Donald Jones

Donald Jones has extensive experience in advisory and board roles in various companies within the healthcare and technology sectors. Currently, they serve as an Advisor at Edge Impulse, Sanguine, Hello Alpha, Inc., ISHI, Codex Health, Inc., Biolinq, and AstraZeneca. Furthermore, they are a Co-founder and Board Member at MYND Therapeutics Inc. and a Co-founder, Advisor, and Board Observer at Tele911. Previously, they held the position of IMPACT Co-Founder, Chair, Virtual First Medical Practice Collaborative at Digital Medicine Society (DiMe). Donald Jones has been actively involved in these roles since at least 2020, with their earliest recorded position starting at AstraZeneca in June 2020.

Donald Jones completed their education with a Bachelor of Arts degree in Biology & Bio-Engineering from UC San Diego from 1976 to 1981. Donald then pursued a Juris Doctor degree at the University of San Diego School of Law from 1981 to 1984. Finally, they attended the University of California, Irvine - The Paul Merage School of Business from 1989 to 1991 to earn an MBA degree.